Investigation of medication adherence and reasons for poor adherence in patients on long-term glaucoma treatment regimes

References

• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267.16488940
   PubMed Web of Science ®Google Scholar
• Varma R, Lee PP, Goldberg I, Kotak S. An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol. 2011;152(4):515–522.21961848
   PubMed Web of Science ®Google Scholar
• Lee PP, Walt JW, Rosenblatt LC, Siegartel LR, Stern LS; Glaucoma Care Study Group. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review. Am J Ophthalmol. 2007;144(6):901–907.17919446
   PubMed Web of Science ®Google Scholar
• NICE. Glaucoma: Diagnosis and Management of Chronic Open Angle Glaucoma and Ocular Hypertension. National Collaborating Centre for Acute Care. London, UK: National Institute for Health and Clinical Excellence; 2009.
   Google Scholar
• Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Nonadherence with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 2005;112(6):953–961.15885795
   PubMed Web of Science ®Google Scholar
• Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101(5):515–523.3706455
   PubMed Web of Science ®Google Scholar
• Okeke CO, Quigley HA, Jampel HD, et al. Adherence with topical glaucoma medication monitored electronically the Travatan dosing aid study. Ophthalmology. 2009;116(2):191–199.19084273
   PubMed Web of Science ®Google Scholar
• Budenz DL. A clinician’s guide to the assessment and management of nonadherence in glaucoma. Ophthalmology. 2009;116(11):S43–S47.19837260
   PubMed Web of Science ®Google Scholar
• Hahn SR. Patient-centered communication to assess and enhance patient adherence to glaucoma medication. Ophthalmology. 2009;116(11):S37–S42.19837259
   PubMed Web of Science ®Google Scholar
• Chang DS, Friedman DS, Frazier T, Plyler R, Boland MV. Development and validation of a predictive model for nonadherence with once-daily glaucoma medications. Ophthalmology. 2013;120(7):1396–1402.23541760
   PubMed Web of Science ®Google Scholar
• Cate H, Bhattacharya D, Clark A, Holland R, Broadway DC. Patterns of adherence behaviour for patients with glaucoma. Eye. 2013;27(4):545–553.23328800
   PubMed Web of Science ®Google Scholar
• Rees G, Chong XL, Cheung CY. Beliefs and adherence to glaucoma treatment: a comparison of patients from diverse cultures. J Glaucoma. 2013;23:293–298.
   Web of Science ®Google Scholar
• Lu VH, Goldberg I, Lu CY. Use of glaucoma medications: state of the science and directions for observational research. Am J Ophthalmol. 2010;150(4):569–574.20678750
   PubMed Web of Science ®Google Scholar
• Rees G, Leong O, Crowston JG, Lamoureux EL. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma. Ophthalmology. 2010;117(5):903–908.20153902
   PubMed Web of Science ®Google Scholar
• Morley AM, Murdoch I. The future of glaucoma clinics. Br J Ophthalmol. 2006;90(5):640–645.16622096
   PubMed Web of Science ®Google Scholar
• Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116(11):S30–S36.19837258
   PubMed Web of Science ®Google Scholar
• Schwartz GF. Compliance and persistency in glaucoma follow-up treatment. Curr Opin Ophthalmol. 2005;16(2):114–121.15744142
   PubMedGoogle Scholar
• Newman-Casey PA, Killeen OJ, Renner M, Robin AL, Lee P, Heisler M. Access to and experiences with e-health technology among glaucoma patients and their relationship with medication adherence. Telemed J E Health. 2018;24(12).
   Web of Science ®Google Scholar
• Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmo. 2015;122(7):1308–1316.
   PubMed Web of Science ®Google Scholar
• Thompson AC, Woolson S, Olsen MK, Danus S, Bosworth HB, Muir KW. Relationship between electronically measured medication adherence and vision-related quality of life in a cohort of patients with open-angle glaucoma. BMJ Open Ophthalmol. 2018;3(1):e000114.
   Web of Science ®Google Scholar
• Buller AJ, Morgan LH, Hercules BL. Patients prefer once-daily glaucoma drops. Graefe’s Arch Clin Exp Ophthalmol. 2007;245(2):293–294.16636837
   PubMed Web of Science ®Google Scholar
• Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC. Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care. 2009;15(6):e22–e33.19514806
   PubMed Web of Science ®Google Scholar
• Friedman DS, Hahn SR, Gelb L, et al. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the glaucoma adherence and persistency study. Ophthalmology. 2008;115(8):1320–1327.18321582
   PubMed Web of Science ®Google Scholar
• Mansouri K, Iliev ME, Rohrer K, Shaarawy T. Compliance and knowledge about glaucoma in patients at tertiary glaucoma units. Int Ophthalmol. 2011;31(5):369–376.21986850
   PubMedGoogle Scholar
• Regnault A, Viala-Danten M, Gilet H, Berdeaux G. Scoring and psychometric properties of the eye-drop satisfaction questionnaire (EDSQ), an instrument to assess satisfaction and adherence with glaucoma treatment. BMC Ophthalmol. 2010;10(1):1.20122146
   PubMed Web of Science ®Google Scholar
• Stryker JE, Beck AD, Primo SA, et al. An exploratory study of factors influencing glaucoma treatment adherence. J Glaucoma. 2010;19(1):66–72.20075676
   PubMed Web of Science ®Google Scholar
• Lacey J, Cate H, Broadway DC. Barriers to adherence with glaucoma medications: a qualitative research study. Eye. 2009;23(4):924–932.18437182
   PubMed Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.3945130
   PubMed Web of Science ®Google Scholar
• Beyhaghi H, Reeve BB, Rogers JE, Stearns SC. Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities Study (ARIC) Participants Value Health. 2016; 19: 996–1001.
   Google Scholar
• Wang Y, Lee J, Ko Y. Validity and reliability of a self-reported measure of medication adherence in patients with Type 2 diabetes mellitus in Singapore Diabet Med. 2012 Sep;29(9):e338–44.
   Google Scholar
• Park MH, Kang KD, Moon J. Nonadherence with glaucoma medication in Korean patients: a multicenter qualitative study. The Korean Glaucoma Compliance Study Group. Jpn J Ophthalmol. 2013; 57:47–56.
   Google Scholar
• Nordmann JP, Baudouin C, Renard JP, Denis P, Regnault A, Berdeaux G. Identification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire. Clin Ophthalmo. 2010; 8: 1489–1496.
   Google Scholar
• Hermann MM, Ustündag C, Diestelhorst M. Electronic adherence monitoring of topical treatment after ophthalmic surgery. Int Ophthalmol. 2010; 30: 385–390.20373127
   PubMedGoogle Scholar
• Robin AL, Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology. 2005; 112: 863–868.15878067
   PubMed Web of Science ®Google Scholar
• Waterman H, Evans JR, Gray TA, Henson D, Harper R. Interventions for improving adherence to ocular hypotensive therapy. Cochrane Database Syst Rev. 2013; 4: CD006132.
   Google Scholar